Copper Peptides: The Evidence and the Limits

Copper peptides are GHK, a three amino acid chain, bound to a copper ion. The laboratory evidence is deep. The human skin evidence is thin. GHK-Cu raises collagen output in fibroblast culture and in animal wounds. It crosses the outer layer of your skin poorly. Most labels never tell you how much is in the bottle.

What are copper peptides and what is GHK-Cu?

GHK is glycyl-histidyl-lysine. Your own plasma carries it. Loren Pickart isolated it from human albumin in 1973. He had noticed that young plasma changed how old liver tissue behaved.

Bind that tripeptide to copper and you get GHK-Cu, listed on labels as Copper Tripeptide-1. Its molecular weight is 402.9 daltons, per the 2025 review in BioImpacts by Mortazavi and colleagues.

One number gets quoted everywhere. Plasma GHK sits near 200 ng/mL at age 20. It falls to about 80 ng/mL by age 60. Both figures come from Pickart and Margolina in the International Journal of Molecular Sciences. Those figures describe your blood. They say nothing about what a serum puts into your face.

What does the copper peptide research actually show?

Sort the literature by what was tested. The picture changes fast.

Study type	What was tested	Finding	What it cannot tell you
Fibroblast culture, Maquart 1988	GHK-Cu in culture medium	Collagen synthesis began between 10-12 and 10-11 M, peaked at 10-9 M	Nothing about a product on skin
Rat wound chamber, Maquart 1993	GHK-Cu injected under the skin	Collagen, glycosaminoglycans and DNA rose with dose	Injection bypasses the barrier entirely
Skin equivalent model, Kang 2009	Copper-GHK on keratinocytes	Integrin, p63 and PCNA expression increased	A lab construct is not living skin
Gene profiling, Pickart 2015	GHK in the Broad Institute Connectivity Map	At least 4,000 human genes shifted up or down	Cell lines, no skin endpoint measured
Randomized trial, Miller 2006	GHK-Cu skincare after CO2 laser, 13 patients completed	No objective wrinkle or redness benefit. Satisfaction scores higher (P = .04)	Small sample, one procedure

A 2026 systematic review in Aesthetic Surgery Journal searched PubMed, Embase and Cochrane CENTRAL. It found 20 eligible studies. Eighteen were preclinical. Two were randomized controlled trials.

The review's clinical findings pull in two directions. Miller 2006 found no objective benefit. The reviewers also report significantly reduced wrinkle volume and depth against controls. The abstract does not say which trial produced that wrinkle result.

Read that count carefully. The review only accepted GHK-Cu as a standalone intervention in aesthetic medicine. Other human studies sit outside those limits.

The 2015 Pickart review describes facial and eye cream reports in groups of 41 to 71 women. The review calls these studies placebo-controlled as a group. Only the 41-woman eye cream report names a placebo arm in its own description. Three such reports appear. Two were 2002 American Academy of Dermatology meeting abstracts. The third is a 2005 book chapter. None of the three is a peer-reviewed journal paper. Both Pickart papers cited here list Skin Biology as the authors' affiliation. Skin Biology sells copper peptide skincare. Both papers declare no conflict of interest. We have not read those primary facial reports ourselves.

The preclinical work is consistent and worth respecting. In those models GHK-Cu increases type I collagen and glycosaminoglycan synthesis. It also modulates matrix metalloproteinase activity and suppresses TGF-beta and IL-6. The 2026 reviewers still describe a translational gap and call for larger controlled trials.

One more finding deserves attention. Choi and colleagues, in the Journal of Peptide Science, tested copper-free GHK in 2012. Its effects on keratinocyte stemness markers resembled those of copper-GHK. The copper may not be the part doing the work.

Why copper peptides struggle to reach the dermis

Collagen lives in the dermis. A copper peptide has to get there to act on the cells the culture studies used.

Molecular weight is not the obstacle here. Bos and Meinardi set out the 500 dalton rule in Experimental Dermatology. They argue that molecules above 500 daltons cannot pass the corneal layer. It is a rule of thumb, not a measured cutoff. GHK-Cu is 402.9 daltons. It passes that test.

Water solubility is the obstacle. The Mortazavi review lists a clogP of -0.94 for GHK-Cu. The workable range for skin permeation is 0 to 4. GHK also carries a charge at physiological pH. Both properties fight the lipid matrix of the stratum corneum.

Anything that does cross then meets skin proteases, which cut peptides apart. A 2025 review in Molecules describes GHK-Cu as "a fairly hydrophilic compound with limited permeation". The barrier it names is the lipophilic stratum corneum. That review also notes how little liposome-encapsulated GHK-Cu transport has been studied.

Measured figures do exist for separated human skin layers. Hostynek and colleagues used flow-through diffusion cells on three of them. Copper reached the receptor phase at 20 percent of applied dose across isolated stratum corneum. Across split thickness skin it was 2 percent. Across entire epidermis it was 0.006 percent. Membrane retention rose 438-fold over baseline in stratum corneum and 31-fold in split thickness skin. The Mortazavi review reports all of these figures. It attributes the high stratum corneum numbers to the absence of the underlying layers, which otherwise retain copper. Separated skin layers in a diffusion cell are not a face.

Not every source agrees. The 2015 Pickart review says GHK-Cu appears to pass the horny layer. It says it does so in quantities sufficient to activate regenerative events. Weigh that against the affiliation noted above. The two 2025 reviews are independent of Skin Biology, and they do not agree with each other. The Molecules review describes permeation as limited. The Mortazavi review calls GHK-Cu relatively skin permeable, while still recommending permeation enhancement methods.

This is the same barrier problem behind every serum that never seems to do anything. Read our explainer on transdermal delivery for the mechanics.

How much copper peptide is in your bottle?

Usually you cannot find out. That is a labeling rule, not an accident.

Under 21 CFR 701.3(f), a cosmetic may list ingredients above 1 percent in descending order of predominance. Everything at 1 percent or less may then be listed "without respect to order of predominance."

Read that again. Below the 1 percent line, position on an ingredient list carries zero information about quantity. An ingredient at 0.5 percent can sit beside one at 0.000001 percent. The brand picks the order.

Here is the arithmetic most people never run. Our guide to ppm in skincare covers the conversion in full.

On the label	Same figure in ppm
1%	10,000 ppm
0.05%	500 ppm
0.001%	10 ppm
0.000001%	0.01 ppm

The trace ingredient problem, including in our own formula

A named ingredient sells the bottle. The named ingredient does not have to be present at any particular level to appear on the panel.

We will use ourselves as the example. Our 03 re:firm-8 Wrinkle Peptide Lifting ampoule contains Copper Tripeptide-1 at 0.000001 percent, which is 0.01 ppm. It also contains Palmitoyl Pentapeptide-4 at 0.0000001 percent, which is 0.001 ppm.

Those are label-dressing levels. We do not build any claim on them, and you should not read them as active dosing. The formula is built around Acetyl Hexapeptide-8 at 500 ppm and Adenosine at 0.04 percent.

We are not going to argue the other way either. Nobody has published a delivered dose for a finished copper peptide product. A bottle concentration is not a measured dose in skin. Between the two sit the barrier, dilution and skin proteases.

That is the honest position. Unknown is a real answer. No published study supplies an absorption multiple for a finished copper peptide product on intact human skin. In-vitro figures do exist for isolated skin layers, and they are quoted earlier in this article. Those are diffusion cell measurements. They do not transfer to a bottle. Ask any brand quoting a multiple to show you the measurement.

Do copper peptides work better after microneedling?

The mechanism is plausible and the evidence is preliminary. Microneedling opens temporary channels through the barrier that stops hydrophilic peptides. The Mortazavi review says only two permeation methods have been evaluated for GHK-Cu and Pal-GHK. Microneedle pretreatment is one. Cell penetrating peptide conjugation is the other. It calls for further work. The 2026 systematic review reports that microneedles and liposomes improved transdermal bioavailability across the studies it collected.

Plausible is not proven. No human clinical trial has compared a copper peptide after microneedling against the same peptide on intact skin. The Mortazavi review does describe a Franz cell comparison by Li and colleagues. On intact human skin samples no peptide and no copper crossed. Across microneedle-pretreated samples about 134 nanomoles of GHK and 705 nanomoles of copper crossed. Laboratory skin in a diffusion cell is not a face.

Safety first, and this part is not optional. Do not microneedle over active acne, cold sores, eczema, psoriasis, keloid-prone skin, or any infected area. Ask a clinician before microneedling if you are taking or have recently taken isotretinoin. Skip it if you take blood thinners or have a bleeding disorder. Speak to a clinician if you are pregnant. If you are unsure whether microneedling suits your skin, ask a clinician first.

Start shallow. Set the shallowest depth your device offers and its lowest intensity. Follow the instructions supplied with whatever device you own. Stop if irritation or swelling does not settle, and stop if the skin breaks. Apply nothing acidic, fragranced or alcohol-based afterwards. Whatever you do apply should be sterile and single use. Our guides on aftercare, side effects and who should not microneedle cover this properly.

Can you use copper peptides with vitamin C or retinol?

The internet states firmly that copper peptides and vitamin C cancel each other out. We looked for the study. We did not find controlled human data either way.

What is defensible is narrower. Copper is a transition metal. Ascorbic acid is a reducing agent. The two can interact inside one formulation. That is a stability question for a chemist mixing one product, not a proven failure in a routine.

The practical answer costs you nothing. Separate them. Use one in the morning and one at night. See how to layer serums and peptides versus retinol.

Are copper peptides worth buying?

That depends on what you expect. A copper peptide product rests on strong cell biology and two randomized trials. One of those two found nothing objective. Other facial cream reports exist. Two are 2002 conference abstracts. One is a 2005 book chapter. All come from an interested party. The delivery problem stays unsolved on paper.

Judge it against alternatives with deeper human evidence, such as retinoids. Read peptides in skincare and do serums actually work before you spend.

Frequently asked questions

Do copper peptides actually work?

In cell culture and animal wounds, clearly yes. On human faces, the base is two randomized trials out of 20 studies. The 2026 Aesthetic Surgery Journal review counted them. Miller 2006 found no objective wrinkle improvement. The same reviewers report wrinkle reduction elsewhere in the clinical data. Anyone promising you a defined outcome is going past the evidence.

Is GHK-Cu better than copper-free GHK?

Unclear. Choi and colleagues reported in 2012 that copper-free GHK produced effects similar to copper-GHK on keratinocyte stemness markers. Copper raises the calculated clogP from -2.24 to -0.94. That is still outside the 0 to 4 window the same review names. The reviewers say the mechanism by which metal complexation increases skin permeability is still an open question. No head-to-head human trial has settled the question either.

How much copper peptide should a serum contain?

No published figure defines an effective topical concentration for human skin. The fibroblast study saw stimulation begin between 10^-12 and 10^-11 M. It peaked at 10^-9 M in culture medium. Those figures do not convert to a bottle percentage. Ask any brand quoting an optimal percentage which study it comes from.

Can copper from skincare build up in your body?

Topical cosmetic levels are very low. The Mortazavi review reports two diffusion cell studies on human skin. In one, nothing crossed untreated skin. In the other, 2 percent of applied copper reached the receptor phase across split thickness skin. The only broken-barrier figure we found is also a diffusion cell one. About 705 nanomoles of copper crossed microneedle-pretreated skin in that experiment. Nobody has measured what happens on a living face. We are not aware of case reports of copper accumulation from cosmetic use. This is general information and not medical advice. Ask your doctor if you have Wilson's disease or another copper metabolism disorder.

How long until copper peptides show anything?

No reliable timeline exists, since the controlled human data is too sparse to give one. Skin turnover takes weeks and slows with age. Any change in the dermis takes months, not days. Treat a four week before-and-after photo as marketing rather than evidence. See how long until skincare works.

Why do copper peptide products cost so much?

Price tracks marketing more than concentration. The 1 percent labeling rule hides quantity. A brand can charge a premium for a peptide present at 0.01 ppm. Nothing on the panel distinguishes that bottle from one holding a hundred times more. Ask for the concentration in writing before you pay.

Should you use a copper peptide after microneedling?

No trial has measured this. The published evidence does not answer the question either way. Keep acids, fragrance and alcohol away from freshly needled skin. Follow the contraindication list above, and start at the shallowest depth.

What we take from all of this

Copper peptides are real biology with a delivery problem and a labeling problem. We sell a device and three ampoules, and our Tap Pen page lists specifications rather than outcomes. We make no claim about what a copper peptide does once you have used it. Nobody has published that measurement, and we are not going to invent one. The labeling problem is one the whole category, including us, should stop hiding behind.

Ask any brand two questions. What concentration, and by what route. Most cannot answer either.

Last updated: 2026-08-20. Written by the re:tones team. This article is general information about cosmetic ingredients. It is not medical advice.